Maverick Capital’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-12,173,094
| Closed | -$65.9M | – | 285 |
|
|
2018
Q3 | $65.9M | Hold |
12,173,094
| – | – | 0.82% | 29 |
|
|
2018
Q2 | $43.2M | Hold |
12,173,094
| – | – | 0.51% | 35 |
|
|
2018
Q1 | $25M | Buy |
12,173,094
+950,000
| +8% | +$1.95M | 0.32% | 40 |
|
|
2017
Q4 | $29.6M | Buy |
11,223,094
+619,150
| +6% | +$1.63M | 0.37% | 31 |
|
|
2017
Q3 | $55.7M | Hold |
10,603,944
| – | – | 0.71% | 31 |
|
|
2017
Q2 | $37.8M | Buy |
10,603,944
+1,530,070
| +17% | +$5.45M | 0.47% | 31 |
|
|
2017
Q1 | $46.9M | Hold |
9,073,874
| – | – | 0.6% | 30 |
|
|
2016
Q4 | $34.5M | Sell |
9,073,874
-21,789
| -0.2% | -$82.8K | 0.45% | 28 |
|
|
2016
Q3 | $81.5M | Buy |
9,095,663
+1,274,855
| +16% | +$11.4M | 0.97% | 26 |
|
|
2016
Q2 | $55M | Buy |
7,820,808
+259,540
| +3% | +$1.83M | 0.75% | 25 |
|
|
2016
Q1 | $64.3M | Hold |
7,561,268
| – | – | 1.02% | 29 |
|
|
2015
Q4 | $99.3M | Buy |
7,561,268
+105,234
| +1% | +$1.38M | 1.43% | 28 |
|
|
2015
Q3 | $27.3M | Buy |
7,456,034
+395,000
| +6% | +$1.45M | 0.47% | 31 |
|
|
2015
Q2 | $40.7M | Hold |
7,061,034
| – | – | 0.62% | 31 |
|
|
2015
Q1 | $41.2M | Buy |
7,061,034
+601,250
| +9% | +$3.51M | 0.66% | 35 |
|
|
2014
Q4 | $50.6M | Hold |
6,459,784
| – | – | 0.79% | 35 |
|
|
2014
Q3 | $31.7M | Hold |
6,459,784
| – | – | 0.46% | 38 |
|
|
2014
Q2 | $39.9M | Hold |
6,459,784
| – | – | 0.57% | 36 |
|
|
2014
Q1 | $34.6M | Hold |
6,459,784
| – | – | 0.48% | 39 |
|
|
2013
Q4 | $33.8M | Buy |
6,459,784
+645,065
| +11% | +$3.37M | 0.44% | 51 |
|
|
2013
Q3 | $32.1M | Buy |
5,814,719
+2,282,766
| +65% | +$12.6M | 0.43% | 52 |
|
|
2013
Q2 | $8.94M | Buy |
+3,531,953
| New | +$8.94M | 0.12% | 55 |
|